Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
Oncolytic Virotherapy · 2020
DOI: 10.2147/ov.s186337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncolytic Virotherapy, 2020. Verfasst von Nadishka Jayawardena und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
- Department of Medicine and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Otago Micro and Nano Imaging, University of Otago, Dunedin, New Zealand.
ORCID-Profile: John T Poirier, Mihnea Bostina
Förderung
- NCI NIH HHS
Zitieren
APA
Jayawardena, N., Poirier, J. T., Burga, L. N., & Bostina, M. (2020). Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development. Oncolytic Virotherapy. https://doi.org/10.2147/ov.s186337
Vancouver
Jayawardena N, Poirier JT, Burga LN, Bostina M. Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development. Oncolytic Virotherapy. 2020. doi:10.2147/ov.s186337
BibTeX
@article{Jayawardena2020,
author = {Jayawardena, Nadishka and Poirier, John T and Burga, Laura N and Bostina, Mihnea},
title = {Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development},
journal = {Oncolytic Virotherapy},
year = {2020},
doi = {10.2147/ov.s186337}
}
EUVIMED